| 230l |
T4 LYSOZYME MUTANT M6L |
1 |
1 |
X-RAY DIFFRACTION |
| 231d |
STRUCTURE OF A DNA-PORPHYRIN COMPLEX |
1 |
1 |
X-RAY DIFFRACTION |
| 231l |
T4 LYSOZYME MUTANT M106K |
1 |
1 |
X-RAY DIFFRACTION |
| 232d |
THE HIGH RESOLUTION CRYSTAL STRUCTURE OF THE DNA DECAMER D(AGGCATGCCT) |
1 |
1 |
X-RAY DIFFRACTION |
| 232l |
T4 LYSOZYME MUTANT M120K |
1 |
1 |
X-RAY DIFFRACTION |
| 233d |
THE CRYSTAL STRUCTURE ANALYSIS OF D(CGCGAASSCGCG)2: A SYNTHETIC DNA DODECAMER DUPLEX CONTAINING FOUR 4'-THIO-2'-DEOXYTHYMIDINE NUCLEOTIDES |
1 |
1 |
X-RAY DIFFRACTION |
| 233l |
T4 LYSOZYME MUTANT M120L |
1 |
1 |
X-RAY DIFFRACTION |
| 234d |
CRYSTAL STRUCTURE OF FOUR MORPHOLINO-DOXORUBICIN ANTICANCER DRUGS COMPLEXED WITH D(CGTACG) AND D(CGATCG): IMPLICATIONS IN DRUG-DNA CROSSLINK |
1 |
1 |
X-RAY DIFFRACTION |
| 234l |
T4 LYSOZYME MUTANT M106L |
1 |
1 |
X-RAY DIFFRACTION |
| 235d |
CRYSTAL STRUCTURE OF FOUR MORPHOLINO-DOXORUBICIN ANTICANCER DRUGS COMPLEXED WITH D(CGTACG) AND D(CGATCG): IMPLICATIONS IN DRUG-DNA CROSSLINK |
1 |
1 |
X-RAY DIFFRACTION |
| 235l |
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT |
1 |
1 |
X-RAY DIFFRACTION |
| 236d |
CRYSTAL STRUCTURE OF FOUR MORPHOLINO-DOXORUBICIN ANTICANCER DRUGS COMPLEXED WITH D(CGTACG) AND D(CGATCG): IMPLICATIONS IN DRUG-DNA CROSSLINK |
1 |
1 |
X-RAY DIFFRACTION |
| 236l |
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT |
1 |
1 |
X-RAY DIFFRACTION |
| 237d |
CRYSTAL STRUCTURE OF A DNA DECAMER SHOWING A NOVEL PSEUDO FOUR-WAY HELIX-HELIX JUNCTION |
1 |
1 |
X-RAY DIFFRACTION |
| 237l |
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT |
1 |
1 |
X-RAY DIFFRACTION |
| 238d |
CRYSTAL STRUCTURE OF THE DNA DECAMER D(AGG(BR)CATGCCT): COMPARISON WITH D(AGGCATGCCT) AND IMPLICATIONS FOR COBALT HEXAMMINE BINDING TO DNA |
1 |
1 |
X-RAY DIFFRACTION |
| 238l |
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT |
1 |
1 |
X-RAY DIFFRACTION |
| 239d |
POLYMORPHISM IN LEFT HANDED DNA: THE CRYSTAL STRUCTURE OF D(CCCGGG)2 |
1 |
1 |
X-RAY DIFFRACTION |
| 239l |
THE RESPONSE OF T4 LYSOZYME TO LARGE-TO-SMALL SUBSTITUTIONS WITHIN THE CORE AND ITS RELATION TO THE HYDROPHOBIC EFFECT |
1 |
1 |
X-RAY DIFFRACTION |
| 23ac |
Crystal structure of TsaGH11 |
2 |
2 |
X-RAY DIFFRACTION |
| 23as |
Structure of Arabidopsis SNX1 (Class l, 7-fold) |
1 |
1 |
ELECTRON MICROSCOPY |
| 23at |
Structure of Arabidopsis SNX1 (Class ll, 6-fold) |
1 |
1 |
ELECTRON MICROSCOPY |
| 23es |
Crystal structure of human PKMYT1 protein kinase domain with Naphthyridinone Inhibitor compound 11 |
2 |
2 |
X-RAY DIFFRACTION |
| 23fc |
Cryo-EM structure of human ATR-ATRIP complex with ATPgammaS and Chk1 |
1 |
1 |
ELECTRON MICROSCOPY |
| 23fh |
Crystal structure of short-form adenosine triphosphate phosphoribosyltransferase from Acinetobacter baumannii at 2.18 angstrom resolution. |
1 |
1 |
X-RAY DIFFRACTION |
| 23fi |
Crystal structure of short-form adenosine triphosphate phosphoribosyltransferase from Acinetobacter baumannii at 1.94 angstrom resolution |
1 |
1 |
X-RAY DIFFRACTION |
| 23fw |
Crystal structure of human PKMYT1 protein kinase domain with Naphthyridinone Inhibitor compound 16 |
2 |
2 |
X-RAY DIFFRACTION |
| 23iv |
Cannabinoid Receptor 1-Gi Complex |
1 |
1 |
ELECTRON MICROSCOPY |
| 23iw |
Cannabinoid Receptor 1-Gi Complex |
1 |
1 |
ELECTRON MICROSCOPY |
| 23jy |
pre-miR-6074 internal loop |
1 |
1 |
X-RAY DIFFRACTION |
| 23jz |
pre-miR-6074 internal loop in complex with amiloride (Form 1) |
1 |
1 |
X-RAY DIFFRACTION |
| 23ka |
pre-miR-6074 internal loop in complex with amiloride (Form 2) |
3 |
3 |
X-RAY DIFFRACTION |
| 23lo |
crystal structure of a flavin dependent Baeyer Villiger monooxygenase from Micromonospora lupini NBC_00409 in complex with FAD |
3 |
3 |
X-RAY DIFFRACTION |
| 23lw |
Crystal structure of SARS-CoV-2 main protease A173V mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23lx |
Crystal structure of SARS-CoV-2 main protease P168 deletion mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23ly |
Crystal structure of SARS-CoV-2 main protease E166V mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23lz |
Crystal structure of SARS-CoV-2 main protease G143S mutant in complex with leritrelvir |
2 |
2 |
X-RAY DIFFRACTION |
| 23ma |
Crystal structure of SARS-CoV-2 main protease H172Y mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23mb |
Crystal structure of SARS-CoV-2 main protease L50F/E166V mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23mc |
Crystal structure of SARS-CoV-2 main protease M49I mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23md |
Crystal structure of SARS-CoV-2 main protease M49I/M165I mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23me |
Crystal structure of SARS-CoV-2 main protease M49I/M165T mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23mf |
Crystal structure of SARS-CoV-2 main protease M165T mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23mg |
Crystal structure of SARS-CoV-2 main protease S144A mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23mh |
Crystal structure of SARS-CoV-2 main protease T21I/E166V mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23mi |
Crystal structure of SARS-CoV-2 main protease M49T mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23mj |
Crystal structure of SARS-CoV-2 main protease Q192L mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23mk |
Crystal structure of SARS-CoV-2 main protease P168 deletion and A173V mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23ml |
Crystal structure of SARS-CoV-2 main protease Q189K mutant in complex with leritrelvir |
1 |
1 |
X-RAY DIFFRACTION |
| 23om |
Crystal Structure Analysis of Bovine Carbonic Anhydrase II to 5-(2-morpholin-4-ylcarbonyl-1,3-oxazol-5-yl)thiophene-2-sulfonamide. |
2 |
2 |
X-RAY DIFFRACTION |